Is it really an ELN you need? Ask the right questions...

Thinking of upgrading from a standard electronic lab notebook (ELN)? Matt Clifford, Director of Research and Innovation Strategy at IDBS, writes about the benefits of centralized BioPharma Lifecycle Management platforms compared to standard ELNs.

While standalone ELNs can still speed up drug discovery, if they don’t form part of a more comprehensive data strategy and ecosystem, they can also get in the way by enabling outdated practices that need a much deeper overhaul.

Read more in this Drug Discovery World article and learn about the benefits that come with an integrated BioPharma research and development system.